EVH - NYSE
Evolent Health, Inc.
$3.78
-4.5%Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
At a Glance
Live Snapshotevh
Total Liabilities and Equity
Last Annual Value
1.90B
3-Year CAGR
1%
5-Year CAGR
5%
10-Year CAGR
6%
Evolent Health, Inc. Competitors Analysis of Total Liabilities and Equity
| Company | Total Liabilities and Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Evolent Health, Inc. NYSE:EVH | 1.90B | -10.8% | 6.0% | 4.7% | |
 Myriad Genetics, Inc. NASDAQ:MYGN | 706.60M | -14.9% | -11.8% | -5.3% | |
 ArriVent BioPharma, Inc. Common Stock NASDAQ:AVBP | 333.17M | 26.9% | 50.6% | N/A | |
 Replimune Group, Inc. NASDAQ:REPL | 551.33M | -5.2% | 0.3% | N/A | |
 Kura Oncology, Inc. NASDAQ:KURA | 738.36M | 18.0% | 6.7% | 26.6% | |
 AMN Healthcare Services, Inc. NYSE:AMN | 2.09B | -10.5% | -7.7% | 5.8% | |
 HealthStream, Inc. NASDAQ:HSTM | 520.37M | 1.3% | 1.3% | 2.8% | |
 MeiraGTx Holdings plc NASDAQ:MGTX | 244.43M | -9.2% | -5.3% | 26.9% | |
 Nutex Health, Inc. NASDAQ:NUTX | 918.52M | 32.1% | 18.4% | 111.6% | |
 Personalis, Inc. NASDAQ:PSNL | 334.16M | 14.1% | -3.4% | N/A | |
 Butterfly Network, Inc. NYSE:BFLY | 296.53M | -0.9% | -12.3% | N/A |
Evolent Health, Inc. Fair Value Envelope
Related Guides
Continue your EVH research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.